Skip to main content
Clinical Trials/NCT06389318
NCT06389318
Completed
Not Applicable

Comparison Between Buccal Midazolam Versus Intranasal Dexmedetomidine Plus Oral Chloral Hydrate in Reducing Parental Separation Anxiety in Children Undergoing Inguinal Hernia Repair: A Randomized Clinical Trial

Benha University1 site in 1 country80 target enrollmentMarch 26, 2023

Overview

Phase
Not Applicable
Intervention
buccal midazolam +oral placebo syrup
Conditions
Inguinal Hernia Repair
Sponsor
Benha University
Enrollment
80
Locations
1
Primary Endpoint
Ramsay sedation score
Status
Completed
Last Updated
last year

Overview

Brief Summary

Inguinal hernia surgery is one of the most common surgical procedures in early infancy. Preoperative anxiety remains a vexing issue, and it exists in nearly 50% of pediatric patients

Detailed Description

Inguinal hernia surgery is one of the most common surgical procedures in early infancy. Preoperative anxiety remains a vexing issue, and it exists in nearly 50% of pediatric patients. The administration of sedatives to a child before entering a surgical room is the most common way of reducing the child's distress and allows the child to undergo smooth anesthesia induction. Chloral hydrate is a widely used sedative for young children undergoing imaging studies, with a high success rate. Dexmedetomidine is a highly selective alpha-2 agonist for paediatric sedation. It produces sedation like natural non-rapid eye movement sleep and has respiratory-sparing effect.

Registry
clinicaltrials.gov
Start Date
March 26, 2023
End Date
April 24, 2024
Last Updated
last year
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Ramy Mousa

Anesthesia and surgical ICU department, Faculty of Medicine, Benha University, Egypt

Benha University

Eligibility Criteria

Inclusion Criteria

  • aged 2 to 7
  • American Society of Anaesthesiology (ASA) І and П scheduled for inguinal hernia repair

Exclusion Criteria

  • sensitivity to dexmedetomidine or midazolam,
  • infection of the upper respiratory tract,
  • severe liver or kidney disease, organ dysfunction,
  • cardiac arrhythmia or congenital heart disease

Arms & Interventions

buccal midazolam group

Children received oral placebo syrup, intranasal 0.9 % normal saline at 0.03 ml/kg and buccal midazolam at 0.1 mg/ kg mixed with simple syrup

Intervention: buccal midazolam +oral placebo syrup

oral chloral hydrate and intranasal dexmedetomidine group

Children received oral chloral hydrate (Chloral Hydrate mixture, concentration at 0.5gm/5ml, 250 ml bottle, at 50 mg /kg, intranasal dexmedetomidine at 2 μg/kg and buccal normal saline.

Intervention: oral chloral hydrate,intranasal dexmedetomidine and buccal normal saline

Outcomes

Primary Outcomes

Ramsay sedation score

Time Frame: RSSs were recorded just immediately before and at 10 minutes , 20 minutes , 30 minutes after dosing

The scoring criteria were as follows: (1) patient shows anxiety and restlessness; (2) patient is cooperative, oriented, and quiet; (3) patient is responsive to instructions; (4) patient shows somnolence and responsive to the tapping of the glabella or to loud auditory stimuli; (5) patient shows somnolence and unresponsive to the tapping of the glabella or to loud auditory stimuli; and (6) patient shows somnolence without any response.

Secondary Outcomes

  • Parental separation anxiety scale(Preoperatively)

Study Sites (1)

Loading locations...

Similar Trials